(Q35627417)

9 August 2017

title

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial (English)

1 reference

adaptive radiation therapy

9 August 2017

main subject

phase III clinical trial

0 references

0 references

1 reference

Richard Cowan

6

0 references

Matthew R Sydes

object named as

Matthew R Sydes

18

0 references

Padraig Warde

object named as

Padraig Warde

1

0 references

author name string

Malcolm Mason

2

1 reference

9 August 2017

Keyue Ding

3

1 reference

9 August 2017

Peter Kirkbride

4

1 reference

9 August 2017

Michael Brundage

5

1 reference

9 August 2017

Mary Gospodarowicz

7

1 reference

9 August 2017

Karen Sanders

8

1 reference

9 August 2017

Edmund Kostashuk

9

1 reference

9 August 2017

Greg Swanson

10

1 reference

9 August 2017

Jim Barber

11

1 reference

9 August 2017

Andrea Hiltz

12

1 reference

9 August 2017

Mahesh K B Parmar

13

1 reference

9 August 2017

Jinka Sathya

14

1 reference

9 August 2017

John Anderson

15

1 reference

9 August 2017

Charles Hayter

16

1 reference

9 August 2017

John Hetherington

17

1 reference

9 August 2017

Wendy Parulekar

19

1 reference

9 August 2017

NCIC CTG PR.3/MRC UK PR07 investigators

20

1 reference

9 August 2017

language of work or name

English

0 references

publication date

2 November 2011

1 reference

9 August 2017

number of pages

8

1 reference

inferred from page(s)

published in

The Lancet

1 reference

9 August 2017

volume

378

1 reference

9 August 2017

issue

9809

1 reference

9 August 2017

page(s)

2104-2111

1 reference

9 August 2017

cites work

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Time trends and local variation in primary treatment of localized prostate cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Treatment strategies for high-risk locally advanced prostate cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

The changing face of prostate cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

A structured literature review to determine the use of the American Society for Therapeutic Radiology and Oncology consensus definition of biochemical failure

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Cardiac and cognitive effects of androgen deprivation therapy: are they real?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

What is the optimal management of high risk, clinically localized prostate cancer?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Duration of androgen suppression in the treatment of prostate cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

An ICRU 50 radiotherapy treatment chart.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Fracture Types and Risk Factors in Men With Prostate Cancer on Androgen Deprivation Therapy: A Matched Cohort Study of 19,079 Men

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243932

Treatment of advanced localised prostatic cancer by orchiectomy, radiotherapy, or combined treatment. A Medical Research Council Study. Urological Cancer Working Party--Subgroup on Prostatic Cancer

15 November 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961095-7

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961095-7

7 January 2021

Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy--Prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961095-7

7 January 2021

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961095-7

7 January 2021

Risk of fracture after androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961095-7

7 January 2021

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961095-7

7 January 2021

10.1016/S0140-6736(11)61095-7

Identifiers

DOI

1 reference

9 August 2017

1 reference

9 August 2017

1 reference